Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK
The oral GLP-1 treatment is now available for eligible adults by private prescription as Lilly seeks NHS access in England.
8 Articles
8 Articles
Britain first in Europe to launch daily weight-loss pill
Britain has become the first nation in Europe to make a new daily weight-loss tablet available to patients, marking another milestone in the country's embrace of GLP-1 treatments. Foundayo, the brand name for orforglipron, is manufactured by the American pharmaceutical giant Eli Lilly and can now be obtained from certain pharmacies across the United Kingdom.The Medicines and Healthcare products Regulatory Agency granted authorisation for the dru…
A new daily pill used to treat type 2 diabetes and aid weight loss has gone on sale in pharmacies in the UK. Offering an alternative for patients who prefer not to receive injections, the drug has prompted authorities to issue warnings about the risk of counterfeit and unlicensed products.
New weight loss pill launches in UK's pharmacies with key difference
Eli Lilly launches oral weight-loss pill Foundayo in UK
Aug 24 (Reuters) - Eli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight management and type 2 diabetes, making it the first country in Europe where the treatment is available. Here are some details: • The pill, kno...
The Independent
The Independent (US)New once-daily weight loss pill now available in pharmacies across UK
The UK was the first country in Europe to approve Foundayo
Coverage Details
Bias Distribution
- 38% of the sources lean Left, 37% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
